- Assist baby's behavioural, immune and gastrointestinal health when taken during pregnancy: Supports baby's immune development and prevention of atopy (allergy and eczema) - 20 billion LGG has demonstrated benefits for childhood atopy and immune development. The highly researched LGG® shows both dose-dependent efficacy and a reduction in atopy (allergy and eczema) when taken in the last trimester and during infancy.
- Support maternal flora balance, glucose metabolism and wellbeing: Up to 10% of pregnant women experience glucose transport problems. An RCT of 10 billion CFU of BB-12® and LGG® was shown to assist maternal glucose metabolism during pregnancy, while 2011 research found that LGG® and BB-12® reduced the occurrence of weight gain following childbirth.
- 2 in 1 formula that can be used by both mother and baby.
- Promotes the growth of infant commensal flora populations. Maternal gut microbiota has a significant impact on infant microbiome and health. Commensal microbiota colonisation is initiated by contact with vaginal microflora during birth, and matures under breast milk and environmental influences. Probiotic strains are transferred from mother to infant via human colostrum and milk during breastfeeding, providing a continuous supply of commensal and potential probiotic bacteria to the infant gut.
- Assists behavioural complaints in later childhood (when taken during pregnancy and infancy). A randomised control trial (RCT) of 159 mother-baby pairs taking 10 billion LGG® daily (prenatally until 6 months) found by 13 years an absence of behavioural complaints, compared to 17% of the control group.
- Reduces symptoms of colic. A double-blind, placebo-controlled, randomised trial involving 192 breastfed infants, 12 weeks of age or less, was conducted using 1 billion of BB-12® daily. The study found that after 21 days, BB-12® reduces the duration of excessive crying and fussing, an increase in sleeping time in infants and an improvement in health-related quality of life for parents.
ELISA tested to ensure 100% dairy free product. ELISA tested to ensure 100% gluten free product. D-lactate free.
Directions:
Pregnant and breastfeeding women:
Take 1 capsule daily to support baby's development.
Take 1 capsule twice daily for maternal health.
Infants (from birth):
Empty the contents of 1 capsule and mix with breast milk, formula or water once daily to support baby's gut flora and immune health.
|
Each capsule contains: | |
|
Lactobacillus rhamnosus (LGG®) |
10 billion CFU (organisms) |
|
Bifidobacterium animalis ssp lactis (BB-12®) |
5 billion CFU (organisms) |
|
Bifidobacterium breve (M-16v) |
5 billion CFU (organisms) |
|
Bifidobacterium longum (BB536) |
5 billion CFU (organisms) |
Free from animal products, dairy protein, lactose, eggs, gluten, wheat, nuts, yeast, soy protein and salt. Free from artificial colours, flavours and preservatives. ELISA tested to ensure 100% dairy free and gluten free product. D-lactate free.
Excipients: Calcium phosphate, Disodium edetate, Gellan gum, Glucose, Hypromellose, Magnesium stearate, Maltodextrin, Potable water, Potassium acetate, Silicon dioxide, Sodium ascorbate and Sucrose.
BB-12® and LGG® are a registered trademark of Chr. Hansen A/S.
Advise your doctor of any medicine you take during pregnancy, particularly in your first trimester.
As a precaution: Safety has not been conclusively established during pregnancy. Practitioner discretion is advised when prescribing for use in pregnancy due to the following cautions:
Pre-eclampsia: A meta-analysis of four clinical trials shows that taking probiotics during pregnancy increases the relative risk of pre-eclampsia.
The specific effects of Lactobacillus rhamnosus (LGG®) and Bifidobacterium animalis ssp lactis (BB-12®) are unclear from this analysis.
Not all cautions and contraindications are listed. For full details, references or more information contact Metagenics in Australia on 1800 777 648 or in New Zealand on 0508 227 744.
- Assist baby's behavioural, immune and gastrointestinal health when taken during pregnancy: Supports baby's immune development and prevention of atopy (allergy and eczema) - 20 billion LGG has demonstrated benefits for childhood atopy and immune development. The highly researched LGG® shows both dose-dependent efficacy and a reduction in atopy (allergy and eczema) when taken in the last trimester and during infancy.
- Support maternal flora balance, glucose metabolism and wellbeing: Up to 10% of pregnant women experience glucose transport problems. An RCT of 10 billion CFU of BB-12® and LGG® was shown to assist maternal glucose metabolism during pregnancy, while 2011 research found that LGG® and BB-12® reduced the occurrence of weight gain following childbirth.
- 2 in 1 formula that can be used by both mother and baby.
- Promotes the growth of infant commensal flora populations. Maternal gut microbiota has a significant impact on infant microbiome and health. Commensal microbiota colonisation is initiated by contact with vaginal microflora during birth, and matures under breast milk and environmental influences. Probiotic strains are transferred from mother to infant via human colostrum and milk during breastfeeding, providing a continuous supply of commensal and potential probiotic bacteria to the infant gut.
- Assists behavioural complaints in later childhood (when taken during pregnancy and infancy). A randomised control trial (RCT) of 159 mother-baby pairs taking 10 billion LGG® daily (prenatally until 6 months) found by 13 years an absence of behavioural complaints, compared to 17% of the control group.
- Reduces symptoms of colic. A double-blind, placebo-controlled, randomised trial involving 192 breastfed infants, 12 weeks of age or less, was conducted using 1 billion of BB-12® daily. The study found that after 21 days, BB-12® reduces the duration of excessive crying and fussing, an increase in sleeping time in infants and an improvement in health-related quality of life for parents.
ELISA tested to ensure 100% dairy free product. ELISA tested to ensure 100% gluten free product. D-lactate free.
Directions:
Pregnant and breastfeeding women:
Take 1 capsule daily to support baby's development.
Take 1 capsule twice daily for maternal health.
Infants (from birth):
Empty the contents of 1 capsule and mix with breast milk, formula or water once daily to support baby's gut flora and immune health.
|
Each capsule contains: | |
|
Lactobacillus rhamnosus (LGG®) |
10 billion CFU (organisms) |
|
Bifidobacterium animalis ssp lactis (BB-12®) |
5 billion CFU (organisms) |
|
Bifidobacterium breve (M-16v) |
5 billion CFU (organisms) |
|
Bifidobacterium longum (BB536) |
5 billion CFU (organisms) |
Free from animal products, dairy protein, lactose, eggs, gluten, wheat, nuts, yeast, soy protein and salt. Free from artificial colours, flavours and preservatives. ELISA tested to ensure 100% dairy free and gluten free product. D-lactate free.
Excipients: Calcium phosphate, Disodium edetate, Gellan gum, Glucose, Hypromellose, Magnesium stearate, Maltodextrin, Potable water, Potassium acetate, Silicon dioxide, Sodium ascorbate and Sucrose.
BB-12® and LGG® are a registered trademark of Chr. Hansen A/S.
Advise your doctor of any medicine you take during pregnancy, particularly in your first trimester.
As a precaution: Safety has not been conclusively established during pregnancy. Practitioner discretion is advised when prescribing for use in pregnancy due to the following cautions:
Pre-eclampsia: A meta-analysis of four clinical trials shows that taking probiotics during pregnancy increases the relative risk of pre-eclampsia.
The specific effects of Lactobacillus rhamnosus (LGG®) and Bifidobacterium animalis ssp lactis (BB-12®) are unclear from this analysis.
Not all cautions and contraindications are listed. For full details, references or more information contact Metagenics in Australia on 1800 777 648 or in New Zealand on 0508 227 744.